first is the oxford university astrazeneca vaccine and the second one is the bharat biotech which isian vaccine for the coronavirus to be recommended and after the approval, it became very clear because this one is very cost effective and it can be styled in a different way and it suits india and most importantly the astrazeneca vaccine is being made locally in india in the western pa rt made locally in india in the western part of india by an institute so this is easily available for india. there are questions over the second one, bharat biotech, there have been opposition politicians questioning about whether enough trials were conducted, what is the efficacy of this particular vaccine. we still don't know about that but the drug regulator was categorical in saying we will not approve anything without considering safety. and what does the roll—out of the vaccines begin and who is the priority, which population groups get it first? the government held a mass drill and india isa government held a mass drill and india is a huge country, if they wa nt to india is a huge country, if the

and here, both vaccines, astrazeneca and the bharat biotech, they involve two doses. they start rolling out. but this has been eagerly anticipated and there are people who are questioning how far these vaccines may be effective. there are some people saying we do not want to vaccine, but overall, what the people want to know, is an assurance from the government and health experts these vaccines are really, really effective so people can take it and the economy can be revived. that was our safe south asia correspondent reporting from delhi. it's emerged that israel has given vaccinations against coronavirus to more thani million people, the highest rate in the world. tom bateman has more. it has been a success story for the israeli government, both in terms of the procurement of the vaccine from pfizer biontech, but also in terms of its delivery. and on that front, there are some natural elements that make it easierfor israel. it is a geographically small country with a small population — around 8 to 9 million people. it is also very practised in mass vaccinations and

and here, both vaccines, astrazeneca and the bharat biotech, they involve two doses.gh stock before they start rolling out. but this has been eagerly anticipated and there are people who are questioning how far these vaccines may be effective. there are some people saying we do not want to vaccine, but overall, what the people want to know, is an assurance from the government and health experts these vaccines are really, really effective so people can take it and the economy can be revived. 0ur south asia editor reporting from delhi. supplies of a coronavirus jab produced by oxford university and astrazeneca are being distributed around britain, in preparation for vaccinations to begin tomorrow. 530,000 doses of the vaccine will be available from tomorrow. nhs england say the jab will be rolled out at a small number of hospitals for the first few days before the bulk of supplies are sent to gp—led services. meanwhile, a group of more than a0 mps have written to the health secretary matt hancock with concerns about the roll—out of the coroanvirus vaccines in the uk — i

and here, both vaccines, astrazeneca and the bharat biotech, they involve two doses.this has been eagerly anticipated and there are people who are questioning how far these vaccines may be effective. there are some people saying we do not want to take the vaccine, but overall, what the people want to know, is an assurance from the government and health experts these vaccines are really, really effective so people can take it and the economy can be revived. our south asia editor with the latest from delhi there. now it's time for a look at the weather with ben rich. hello. the cold and wintry weather we've had to start 2021 shows no sign of letting up through the week ahead. it is going to stay pretty chilly out there with a mixture of rain, sleet and snow at times, but not all the time. there will also be some spells of sunshine. through the rest of sunday into the night, we will see for this —— further showers streaming in from the east, rain at low levels but some sleet and snow even over fairly modest hills, and some ice likely across parts of eastern scotland and

a drug based on the astra zeneca vaccine kovacs in a drug created by india's bharat biotech company a senior health official said that both jobs are 110 percent say they wouldn't have been approved if there were any safety concerns but not everyone so confident. based on the full goes regimen for both shots that got approved astra zeneca had a chance 62 percent efficacy this is much lower than any other vaccine that has been approved in many countries the all india drug action network is shocked to learn of a c.c.s. recommendation to grants approval of bharat's biotechs kovacs in its appears that no efficacy data for the vaccine candidate was submitted from the phase 3 trials that are ongoing and completely confused parent has some data in preparation but as far as i'm aware there is absolutely no efficacy data that has been presented published earlier we spoke to public health experts among good to who believes the indian government may have bucked the wrong party. in the in the fields of science and public health quite astonished to see. if you just look from the the data which is a

based astra zeneca and oxford university and the other by local company bharat biotech the government is preparing the rollout of a nationwide inoculation program. police in norway say the death toll has risen to 4 following a landslide in austin northeast of oslo several people are still missing after the landslide tore into the village early on wednesday but rescuers say they have found no signs of life landslide is the worst in modern norwegian history. u.s. senator ted cruz state says he will be among about a dozen republican senators who will challenge joe biden's presidential victory over donald trump when electoral college results are tallied in congress next week they're demanding an emergency investigation into voter fraud accusations that have been rejected by courts and election authorities held a higher standard as has in the west african country of new share gunmen have killed at least 70 people and wounded 20 interior minister says the militants targeted 2 villages situated near the border with mali is calling it a suspected terrorist attack number of islamist groups are

recommendation to grants approval of bharat's biotechs kovacs in its appears that no efficacy data for the vaccine candidate was submitted from the phase 3 trials that's ongoing i'm completely confused parent has some data in preparation but as far as i'm aware there is absolutely no efficacy data that has been presented published earlier we spoke to public health experts among gupta who believes the indian government may have bucked the wrong poxy all of us in the in the fields of science and public health are quite astonished to see. if we just look at it from the the data which is available to us that astra zeneca vaccine we're looking at in africa 62 percent. said on be don't really have the necessary efficacy read so i think from that particular perspective for a country with 1300000000 people to provide a rule for these 2 vaccines may not be one of the most strategy and the best decision to be taken i think there are other vaccines in the world and the government should have considered others from in africa see the. love as her love for not but more great programs get their start

based astra zeneca and oxford university the other by local company bharat biotech the government is preparing the rollout of nationwide knock elation program. let's take a look at some of the other developments in the pandemic the u.k. has recorded another daily record of new infections with the number exceeding 50000 for the 5th straight day saudi arabia has lifted a ban on travelers entering the kingdom it was put in place 2 weeks ago over fears about a new virus variant circulating widely in the u.k. scientists believe the variant is more infectious and norway has ordered mandatory test for anyone arriving into the country. now 2020 will be remembered for the coronavirus pandemic which is far from over restrictions and lockdowns have had a huge impact on the younger generation and how have they dealt with it how has it changed their lives our reporters talked to 4 young people living in berlin. if i think of trying the. think of. this most of the grants. to get there is you don't know how this is called. because once complained loudly. that i had. one out of present. when i was p

haslinda: bharat biotech founder krishna ella.n vaccines have been given around the world, but with infection number is surging, there is still a long way to go. some countries have been criticized for a lagging response. joining us now is managing editor emma o'brien. how is the vaccine rollout so far? emma: different countries seem to be taking pretty different approaches. you have some places like the u.s., the u.k., israel among them, that are being quite aggressive in their rollout. it is not a coincidence that those countries are experiencing still very bad, almost unbridled outbreaks. so the incentive is very much there. somee u.s. has rolled out 4.3 million doses so far, which is only 1.3% of the population by our calculation. the u.k. has had a similar percentage at 1.4%. israel interestingly is very much focused on the vaccine rollout. it has inoculated just over 12% of its population, the most worldwide. sheer numbers, china in front with more than 4.5 million doses apparently administered. had emergency authorization f

reforms what can you tell us about that just quickly sasha baron cohen for example as in the role of bharat and he was also very critical about social media and he posted this facebook and twitter getting trump a little time out is not enough to investigate an act of domestic terrorism against america facebook and twitter have banned other extremists permanently they must bend trump permanently now but to be honest i don't know if this is the solution solution big because they are already so many other alternative platforms right like like parlor where all the yes the far right have gone michael kruger thanks very much. and i'm joined by my next guest now american political filmmaker and former white house videographer to president obama around choudary around thanks for coming on arts and culture you have built a career on the emotional and political impact of images so what was going through your mind when you saw these pictures of men and women storming the u.s. capitol yeah really striking images and i think my immediate reaction is probably similar lot of people in which i thought thes

recommendation to grant's approval of bharat's biotechs kovacs in its appeared. no efficacy data for the vaccine candidate was submitted from the phillies 3 trials that are ongoing and completely confused parrot has some data in preparation but as far as i'm aware there is absolutely no efficacy data that has been presented published. it is being live on the line now 2 millennia i saw the news the co convener of the all india drug action network welcome to r.t. and we saw a quote there from your organization i believe so 1st of all why as an institution you unhappy with the approval of the vaccine and astronomical jobs in india. so we have concerns in respect of the of provos in respect of the biotechs vaccine the callback seen of course the primary concern is the lack of ethical cd doubt because the phase 3 trial is still ongoing in india and currently it is too early for there to be any data for any interim analyses to have taken place the data so far in humans is limited to $755.00 participants in the face one in phase 2 trials which were looking at safety and

coronavirus vaccines the astra zeneca oxford one and a 2nd vaccine called kovacs and developed locally by bharat biotech production facilities in the country will manufacture both jabs prompting a triumphant prime minister narendra modi to comment in a twitter post that it makes every indian proud not all indians feel as excited though with some experts expressing concern over the government's lack of transparency and for its authorization of kodak's in which is still in clinical trials the general public reflects that ambivalence with a recent survey showing that 69 percent of indians are in no rush to be 1st in line . everybody's saying if it has so many fade effect. it might have something to make that not good for you that make a film that is taking the oath and then you'll hear the anger that will. it get back to a normal life. or vendor very soon again and then different i'm ready i'm ready to take the thought and. get it as soon as it arrives it means safety for us thanks a nation is safe for our bodies and if i don't get it because of what other people say and i can track over 19 whom do

the second co—vaccine, developed by an indian company, bharat biotech, is yet to pass its phase threech means even though officials say it's safe, we still don't know how effective it is. there's been widespread concern its approval was rushed. junior doctors at a delhi hospital told me they won't be taking it yet. the phase three efficacy data is not out yet for this vaccine, which is being administered here. as doctors, we believe in science, so at this moment, we will not be going for this vaccine. we don't want to be the guinea pigs. persuading people to take the vaccine is just one challenge in a nation hit hard by covid—i9. here, they're burning a coronavirus effigy to celebrate the start of the vaccine drive. it's been a dark year for this vibrant nation. today, indians are hoping they've turned a corner. rajini vaidyanathan, bbc news, delhi. dr swapneil parikh is a clinical researcher from the kasturba hospital of infectious diseases in mumbai. he told us more about covaxin, which india developed domestically. the vaccine is a whole vaccine inactivated vaccine and it has been

recommendation to grants approval of bharat biotechs kovacs in its appears that no efficacy data for the vaccine candidate was submitted from the phase 3 trials that are ongoing i'm completely confused parent has some data in preparation but as far as i'm aware there is absolutely no efficacy data that has been presented published . ok let's discuss this further now but dr and barney's a former president of the international association of bioethics and he is one of the skeptics to just quickly pursed 1st thanks for coming on but just quickly the indian prime minister says that the code vaccine job is a game changer why the skepticism. sure thank you for having me so i think you know all of us who have been raising some concerns with regards to these vaccine approve worlds are strong supporters of indian science and the indian magazine industry which actually has played an important role in global health the concerns here out about primarily a lack of transparency in that a greater process we know that this decision has been taken but it's not very clear right now on what basis the d

decided to accept the recommendations of the expert committee and accordingly vaccines of m/s serum and bharatiotech are being approved for restricted use in emergency situation and permission is being granted to m/s cadila healthcare for conduct of the phase iii clinical trials in india. with the approval of oxford university astrazeneca and the indian—made covaxin jabs, the roll—out can happen within weeks. astrazeneca has tied up with a local partner to produce the vaccine in india. the indian prime minister, narendra modi, expressed hisjoy for the fact that both the vaccines will be produced in india, but within hours of the approval of the two vaccines, controversy has erupted. the opposition raising concerns over the permission given to the locally made covaxin. critics argue that safety and efficacy of the vaccine has not been reviewed. but the drug regulatory authority said both the vaccines were safe to use. experts say the government needs to allay the fears over the vaccine. i think the way to deal with resistance is to have a very strong communication strategy. that needs to be dev

no data to say the 1st those kids protection beyond 21 days british infectious diseases expert dr bharat pollack near the 2nd job can't be held up indefinitely. the 2nd dose is crucial in boosting the immune levels so if you are sub optimally immunized and then you never get that boost that immunity will eventually start to frayed and you become one rable to infection we have to immunize as many as possible as fast as possible and i accept giving the one vaccine prevents severe illness in more people by using up the 2 doses to give to double the number of people accept that but if we then fail to boost their immunities in a given time span then we may be losing the protective effect of the 1st vaccine that we gave if that is the case it's very unfortunate therefore the 2nd vaccine ought to be given within a good time frame not an indefinite time interval worlds apart with r.t. 6 out of work are coming up next that's when i retired in hoff allowed to keep your right up to speed on the global news headlines join us again but. the other financial survival today was all about money launderin

is no data to say the 1st dose gives protection on 21 days british communicable diseases expert dr bharat says the 2nd job can't be held up indefinitely the 2nd dose is crucial in boosting the immune levels so if you are so optimally immunized and then you never get that boost that immunity will eventually start to frayed and you become one rable to infection we hope to immunize as many as possible as fast as possible and i accept giving the one vaccine prevents severe illness in more people by using up the 2 doses to give to double the number of people accept that but if we then fail to boost their immunities in a given time span then we may be losing the protective effect of the 1st vaccine that we gave if that is the case it's very unfortunate therefore the 2nd vaccine ought to be given within a good time frame not an indefinite time interval. meanwhile doctors in the u.k. are reportedly being told to throw away left over crowded iris facts scenes similar incidents have been reported across the atlantic as well one health specialist share the story of a doctor who could not give left o

recommendation to grants approval of bharat's biotechs kovacs in its appears that no efficacy data for the vaccine candidate was submitted from the fees 3 trials that are ongoing i'm completely confused parent has some data in preparation but as far as i'm aware there is absolutely no efficacy data that has been presented published public health expert allman group to fears the indian government might have backed the wrong vaccine. in the in the face of science and public health. astonished to see and if you just look from the detail which is available to us the astros' the neko vaccine we had to create in africa cd 62 wasn't the. be don't have the and this is the i think you see it so i think from that particular perspective for a country with 1300000000 people who provide proof of these 2 vaccines minogue be one of the most strategy and the best decision to be taken. by those vaccines in the water and should have the moment if we could see the. that's it for this hour for more on your world news stories make sure to check us out r.t. dot com and follow us on twitter i'll be back with

coronavirus vaccines the astra zeneca oxford one and a 2nd vaccine called kovacs in developed locally by bharat biotech production facilities in the country will manufacture both jabs prompting a triumphant prime minister narendra modi to comment in a twitter post that it makes every indian proud not all indians feel as excited though with some experts expressing concern over the government's lack of transparency and for its authorization of kodak's in which is still in clinical trials the general public reflects that ambivalence with a recent survey showing that 69 percent of indians are in no rush to be 1st in line . everybody's saying if it has them any fade effect. it might have some type of thank you they're not good for you. to learn that if they are then you'll hear the other that in the full. effect we're not going to lie for. our vendor vincent gave them the printed i'm ready i'm ready to take a thought and. get it as soon as it arrives it means safety for us faction nation is safe for our buddies and if i don't get it because of what other people say and i can try covert 19 whom does

the second, covaxin, developed by an indian company, bharat biotech, is yet to pass its phase three trialsdon't know how effective it is. there's been widespread concern its approval was rushed. junior doctors at a delhi hospital told me they won't be taking it yet. the phase three efficacy data is not out yet for covaxin, which is being administered here. as doctors, we believe in science, so at this moment, we will not be going for covaxin. we don't want to be the guinea pigs. persuading people to take the vaccine is just one challenge in a nation hit hard by covid—i9. here, they're burning a coronavirus effigy to celebrate the start of the vaccine drive. it's been a dark year for this vibrant nation. today, indians are hoping they've turned a corner. rajini vaidyanathan, bbc news, delhi. let's get some of the day's other news: the number of coronavirus deaths in france has passed 70,000. britain and italy are the only european countries with a higher number of deaths. all of france is now under a six pm curfew. but the authorities say their vaccination programme is gathering pace, havin

bharat narumanchi was holding five workers hostage, including dr. katherine lindley dodson. hostages telling police narumanchi was allegedly armed with a pistol and what appeared to be a shotgun. >> he told the hostages to tie themselves up. some of the hostages were able to escape and some of them were ultimately released. >> reporter: with only dodson left in the office, negotiators tried to speak to narumanchi. and when s.w.a.t. officers finally entered the building, they found both doctors dead. police calling it a murder-suicide. today, a community's pain on full display at the tragic scene. dodson's family saying in a statement, "she brightened our lives and lifted us up with her laughter, which was like magic." authorities say the 43-year-old suspect, also a pediatrician, had recently been diagnosed with terminal cancer and given weeks to live. >> we feel like his terminal cancer probably played a large part in whatever it was that occurred in his life and what was happening yesterday. >> reporter: david, police say narumanchi visited that office in the last week or t

recommendations of grants approval of bharat's biotechs kovacs in its appears that no efficacy data for the vaccine candidate was submitted from the phase 3 trials that's only going. and earlier we spoke to public health experts among the group who believes the indian government might have buck thing wrong in. the in the fields of science and public health. astonished to see. if we just look from the the data which is available to us the astra zeneca vaccine we're looking at in africa see the 60 wasn't. don't be don't really have the and this is the efficacy of so i think from that particular perspective for a country with 1200000000 people who provide a rule for these 2 vaccines mean not be one of the most strategy and the best decision to be there are other vaccines in the water and the government should have considered others from in africa see the. more great programs get their start in moments here all are to stay close to find out what's showing reverie you are today by for naught. hello and welcome to cross talk or all things are considered i'm peter lavelle what is the fate of t

coronavirus vaccines the astra zeneca oxford one and a 2nd vaccine called kovacs and developed locally by bharat biotech production facilities in the country will manufacture both jabs prompting a triumphant prime minister narendra modi to comment in a twitter post that it makes every indian proud. not all indians feel as excited though with some experts expressing concern over the government's lack of transparency and for its authorization of callbacks in which is still in clinical trials the general public reflect that ambivalence with a recent survey showing that 69 percent of indians are in no rush to be 1st in line . everybody saying we're pretty far from any side effects. it might have from try to pick whichever are good for you here that remember the good news in the new year you are about the one who. you can get back to a normal life. or to vent or vent seem to care for it i am ready i'm ready to take a thought for them to. get it as soon as it arrives it means safety for us thanks a nation is safe for our bodies and if i don't get it because of what other people say and i can try cover

approved two vaccines against covid-19 -- the oxford-astrazeneca vaccine and domestically develop bharat biotech's covaxin. some health expertand politicians expressed concern ov its approval with the publication of its efficacy. india aims to inoculate 300 million frontline workers, horribled will people out of its 1.35 billion population by august. britain became the first country today to start administering doses of the oxford-astrazeneca vaccine. in related news, the world health organization listed pfizer-biontech's covid-19 vaccine for emergency use thursday, which should allow less wealthy countries to expedite their own regulatory approval for the vaccine. in the middle east, over one million israelis, or over one -10th of the population has already received their first dose of the pfizer-biontech shot, the highest rate of vaccination against e coronavirus in the world. but human rights groups say israeli authorities are excluding palestinians in the occupied territories from the vaccine rollout, even as settlers in those regions receive the shots. palestinian authorities say th

immunization campaign both the oxford astra zeneca vaccine and another made by indian drug maker bharat biotech have been approved for emergency use shelob ellis reports. outside the was a story heavy rain thunder and lightning lit up the delhi sky but india with the worst conditions in 2020 recorded more than 10000000 cases of covert 19 and around 150000 deaths inside at a news conference in delhi on sunday there was hope that storm may pass after a record examination. the 30 years your has decided to accept a common they found subject court and accordingly that scene for us and bothered by it there are being approved forestry paired you with an emergency situation the announcement was a formality the begins the world's biggest vaccination campaign against corona virus. one vaccine was developed by oxford astra zeneca and another by indian drug maker biotech both a cheaper and easier to distribute than other covered $900.00 vaccines or though they both require 2 doses and must be stored between $2.00 and $8.00 degrees the ox with astra zeneca jab has an efficacy of 70 percent and movie

bharat's is a professor of economics and director of the development policy research unit at the university of cape town and he says it's the largest contraction of south africa's economy in modern economic history. i think what's happened as with most emerging markets and certainly on the african continent as well and globally is a massive contraction saw growth or cost or 2020 indicate an average consensus contraction of about 6 and a half percent relative to last year say fate of li is seeing the largest contraction in south africa's modern economic history. and the consequences of that 2200000 jobs lost at the last count what's going to happen is we are probably going to as as loft on eases and assuming that we don't have a 3rd wave. come back on stream across the board including those in the tourism sector and you're going to see a probably a push an increase in growth rates 2021 average consensus again of about 3 percent and let terms it still means that we are not quite back where we were created covert 19 but it means some woman for it in terms of jobs what's going to happen i think

and joining me to answer your questions are dr bharat pankhani, senior clinical lecturer at the university welcome, as ever, and thank you forjoining us again to a nswer and thank you forjoining us again to answer our viewers questions. the first is from dave matthews for you, dr pankhani. can a gp deliver both types of the vaccine safely? talking about presumably the pfizer/biontech and the oxford astrazeneca vaccine. yes, of course they can deliver it safely. having said that, the oxford astrazeneca vaccine is a lot easier to give because of the storage requirements for the pfizer/biontech vaccine to be maintained at —70 celsius. difficult to give, of course it can be given. the easier one to give is the oxford astrazeneca one. which opens at the possibility of it being administered lots of different settings, notjust in hospitals or gp surgeries. indeed, and that is the plan that the oxford astrazeneca vaccine will be given from many, many different portals, including mass vaccination centres, community pharmacists and of course our gp practices as well. professor griffiths, wayne on tw

bharat narumanchi was holding five workers hostage at a pediatric doctor's office. >> there were no patients or children that were at the building when the suspect arrived on scene. >> reporter: police say narumanchi had multiple guns when he walked into the building. >> he displayed a gun and told the hostages to tie themselves up. some of the hostages were able to escape and some of them were ultimately released. >> the doctor is still inside. >> reporter: the last hostage, 43-year-old dr. katherine dodson a mother of three could not escape. for hours negotiators tried to speak with narumanchi but when s.w.a.t. entered that building both doctors were found dead. >> our hearts are just in a place that we can't even describe how sad we are. >> reporter: overnight members of the community reflecting on dr. dodson's impact. >> as a physician you're ready to sacrifice your life and your time and your children. that's exactly what she did. she's a true hero. >> reporter: the dodson family sharing a statement saying, as a dedicated mom, wife, daughter, friend and pediatrician she radiated light,

we can speak now to dr bharat pankhania, senior clinical lecturer, university of exeter medical schoolhat, we would be in a better place and if we are not going to adhere to strong infection—control measures, u nfortu nately, we infection—control measures, unfortunately, we will end up with tighter regulation. i am distressed to hear that we are arguing about what local means. it implies to me that people have not been taken together about adhering to standard infection measures that we do know about. but, i mean, isn't it inevitable that it will get argued about when there is no actual clarity on when we are told that the prime minister going for a cycle ride seven miles away from downing street is not against the rules? yes. if we had got our messaging clear, correct and strong from the beginning, we wouldn't be debating about all these things about whether seven about all these things about whether seven miles is local or not, because what we would have done instead is taken our what we would have done instead is ta ken our people what we would have done instead is taken our people

dr bharat pankhania is a senior clinical lecturer at university of exeter medical school.h several colleagues of mine, directors of public health, and the case numbers are vertical. they were 100,000. that is very high. we are not in control. we need to regain control in a shorter time as is possible. those figures are full—time what they were four weeks ago. is this down to the new variant? i refuse to accept that, because whether it is a new variant of the old variant you are getting infected, and with respect, getting infected, and with respect, getting infected means you are dropping your infection control guard. these are the seed sown from people interacting in the pro to christmas, and to have got infected and have gone on to make more and more cases. we have not got the figures for christmas and new year yet. we have not got the figures for christmas and new year yetm we have not got the figures for christmas and new year yet. it is very worrying because i‘m dealing with outbreaks every day and several nursing homes and residential homes, schools and things, etc. t